Clinical trial
A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418
NCT05995782
Study timeline
Study start (actual)2023-12-20Date precision: day
Registry last updated2024-12-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson Disease Psychosisunresolved
Amyotrophic Lateral Sclerosis (ALS)unresolved
Interventions
FB418DRUG
Sponsors & collaborators
1ST Biotherapeutics, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05995782 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.